Document is current

Article History

Received: 21 February 2024

Accepted: 31 July 2024

First Online: 16 August 2024

Declarations

:

: Juan Cristobal Sanchez reports payment or honoraria for lectures, presentations, speakers bureaus or educational events from Roche, MSD, Bristol Myers Squibb, Sanofi, Pfizer, Novartis, Lilly and Daychi-Sankyo. Support for attending meetings and/or travel from Roche, MSD, Pfizer, Bristol Myers Squibb, Pierre-Fabre and Novartis. Beatriz Nuñez-Garcia reports payment or honoraria for lectures, presentations, speakers bureaus or educational events from Pfizer and Daychi-Sankyo. Virginia Calvo reports consultant fees from Roche, Bristol Myers Squibb, MSD, AstraZeneca, Takeda, Amgen and Sanofi. Payment or honoraria for lectures, presentations, speakers bureaus or educational events from Roche, AstraZeneca, MSD, Bristol Myers Squibb, Takeda, Sanofi and Amgen. Support for attending meetings and/or travel from AstraZeneca, Roche, MSD and Takeda. Virginia Calvo serves as an associate editor of Clinical and Translational Oncology. Blanca Cantos reports consultant fees from Roche, MSD, Bristol Myers Squibb, Sanofi, Pfizer, Novartis, Lilly, AstraZeneca and Daychi-Sankyo. Payment or honoraria for lectures, presentations, speakers bureaus or educational events from Roche, MSD, Bristol Myers Squibb, Sanofi, Pfizer, Novartis, Lilly, AstraZeneca, Pierre-Fabre and Daychi-Sankyo. Support for attending meetings and/or travel from Roche, MSD, Pfizer, Novartis, AstraZeneca and Daychi-Sankyo. Miriam Mendez reports payment or honoraria for lectures, presentations, speakers bureaus or educational events from Roche, MSD, Bristol Myers Squibb, Sanofi, Pfizer, Novartis, Lilly and Daychi-Sankyo. Support for attending meetings and/or travel from Roche, Pfizer, Bristol Myers Squibb, Novartis and Daychi-Sankyo. Ana Collazo-Lorduy reports consultant fees from AstraZeneca. Payment or honoraria for lectures, presentations, speakers bureaus or educational events from Takeda and Janssen. Payment for expert testimony from AstraZeneca. Support for attending meetings and/or travel from Takeda, MSD, Janssen and Bristol Myers Squibb. Participation on a Data Safety Monitoring Board or Advisory Board for AstraZeneca. Mariano Provencio reports research funding received from MSD, AstraZeneca, Roche, Bristol Myers Squibb, Takeda, Boehringer Ingelheim and Amgen. Consultant fees from Bristol Myers Squibb, AstraZeneca, MSD, Roche, Takeda, Eli Lilly, F. Hoffman-La Roche, Janssen, Pfizer and Amgen. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Bristol Myers Squibb Company, AstraZeneca, MSD, Roche, Takeda, Eli LIlly, F. Hofmann-La Roche, Janssen, Pfizer, MSD and Amgen. Support for attending meetings and/or travel from Bristol Myers Squibb, AstraZeneca, MSD, Roche, Takeda, Eli Lilly, F. Hoffman-La Roche, Janssen, Pfizer, Amgen, Boehringer Ingelheim, Phierre Fabre Pharmaceuticals and Janssen. Mariano Provencio serves as an Editor-in-Chief of Clinical and Translational Oncology. The ohers authors have no conficts of interest to declare.

: This study adhered to the ethical principles of the Declaration of Helsinki (2013). The use of information exclusively for scientifc purposes was guaranteed, and the right to privacy was protected by omitting the identifying data of the participating subjects. The study protocol was approved by the institutional ethics committee of the Hospital Universitario Puerta de Hierro, Majadahonda, Madrid. Because of the retrospective design and deidentified data, informed consent was waived for participants.